AstraZeneca FDA approves Seroquel maintenance treatment in bipolar … - CNBC
LONDON (Thomson Financial) - AstraZeneca Plc, the UK’s second biggest drugmaker, has announced that the U.S. Food and Drug Administration (FDA) has approved Seroquel for the maintenance treatment of patients with bipolar I disorder, as adjunct to …